Molecular Imaging and Therapy

OrgUnit's Researchers
(Persons)

Results 1-5 of 22 (Search time: 0.004 seconds).

FullnameTranslated NameEmail
Ackermann, UweUwe.ACKERMANN@austin.org.au
Alexander, Paschal KPaschal.ALEXANDER@austin.org.au
Bozinovski, SvetlanaSvetlana.BOZINOVSKI@austin.org.au
Chan, J Gordongordon.chang@austin.org.au
Doré, VincentVincent.DORE@austin.org.au

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 481-500 of 693 (Search time: 0.018 seconds).

Publication YearTitleAuthor(s)
4811-Jul-2012PET in prostate and bladder tumors.Lee, Sze Ting ; Lawrentschuk, Nathan; Scott, Andrew M 
482Oct-2015PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer.Zanzonico, Pat; Carrasquillo, Jorge A; Pandit-Taskar, Neeta; O'Donoghue, Joseph A; Humm, John L; Smith-Jones, Peter; Ruan, Shutian; Divgi, Chaitanya; Scott, Andrew M ; Kemeny, Nancy E; Fong, Yuman; Wong, Douglas; Scheinberg, David; Ritter, Gerd; Jungbluth, Achem; Old, Lloyd J; Larson, Steven M
483Jan-2024PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group.Albert, Nathalie L; Galldiks, Norbert; Ellingson, Benjamin M; van den Bent, Martin J; Chang, Susan M; Cicone, Francesco; de Groot, John; Koh, Eng-Siew; Law, Ian; Le Rhun, Emilie; Mair, Maximilian J; Minniti, Giuseppe; Rudà, Roberta; Scott, Andrew M ; Short, Susan C; Smits, Marion; Suchorska, Bogdana; Tolboom, Nelleke; Traub-Weidinger, Tatjana; Tonn, Joerg-Christian; Verger, Antoine; Weller, Michael; Wen, Patrick Y; Preusser, Matthias
4841-May-2019Phantom measurement predicts the impact of image reconstruction on Florbetapir SUVR quantificationWilliams, Robert; Johnston, Leigh; Dore, Vincent; O'Keefe, Graeme J; Callahan, Jason; Xu, Zhihan; Zheng, Shuning; Moffat, Bradford; Masters, Colin; Rowe, Christopher C 
4859-Jun-2012Pharmacodynamic analysis of tumour perfusion assessed by 15O-water-PET imaging during treatment with sunitinib malate in patients with advanced malignancies.Scott, Andrew M ; Mitchell, Paul L R ; O'Keefe, Graeme J; Saunder, Timothy; Hicks, Rodney J; Poon, Aurora M T ; Baum, Charles; Brega, Nicoletta; McCarthy, Timothy J; Toner, Guy C
4862021Pharmacogenomics in Radionuclide Therapy: Impact on Response to Theranostics.Scott, Andrew M ; Bodei, Lisa
4871-Jun-2021A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.Gan, Hui K ; Burge, Matthew; Solomon, Benjamin; Lee, Sze Ting ; Holen, Kyle D; Zhang, Yumin; Ciprotti, Marika; Lee, F T; Manusinghe, Wijth; Fischer, Judee; Ansell, Peter; Fox, Gerard; Xiong, Hao; Reilly, Edward B; Humerickhouse, Rod; Scott, Andrew M 
488Aug-2022A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers.Gan, Hui K ; Parakh, Sagun ; Lee, Fook-Thean; Tebbutt, Niall C ; Ameratunga, Malaka; Lee, Sze Ting ; O'Keefe, Graeme J; Gong, Sylvia J; Vanrenen, Christine; Caine, Jaren; Giovannetti, Mara; Murone, Carmel ; Scott, Fiona E; Guo, Nancy; Burvenich, Ingrid J G; Paine, Cameron; Macri, Mary J; Kotsuma, Masakatsu; Senaldi, Giorgio; Venhaus, Ralph; Scott, Andrew M 
48913-Oct-2009Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers.Herbertson, Rebecca A; Tebbutt, Niall C ; Lee, Fook-Thean; MacFarlane, David J; Chappell, Bridget; Micallef, Noel; Lee, Sze-Ting; Saunder, Timothy; Hopkins, Wendie; Smyth, Fiona E; Wyld, David K; Bellen, John; Sonnichsen, Daryl S; Brechbiel, Martin W; Murone, Carmel ; Scott, Andrew M 
4901-Jun-2007A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen.Scott, Andrew M ; Tebbutt, Niall C ; Lee, Fook-Thean; Cavicchiolo, Tina; Liu, Zhanqi; Gill, Sanjeev; Poon, Aurora M T ; Hopkins, Wendie; Smyth, Fiona E; Murone, Carmel ; MacGregor, Duncan; Papenfuss, Anthony T; Chappell, Bridget; Saunder, Timothy H; Brechbiel, Martin W; Davis, Ian D; Murphy, Roger; Chong, Geoffrey ; Hoffman, Eric W; Old, Lloyd J
4911-May-2003A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.Scott, Andrew M ; Wiseman, Greg; Welt, Sydney; Adjei, Alex; Lee, Fook-Thean; Hopkins, Wendie; Divgi, Chaitan R; Hanson, Lorelei H; Mitchell, Paul L R ; Gansen, Denise N; Larson, Steven M; Ingle, James N; Hoffman, Eric W; Tanswell, Paul; Ritter, Gerd; Cohen, Leonard S; Bette, Peter; Arvay, Lisa; Amelsberg, Andree; Vlock, Dan; Rettig, Wolfgang J; Old, Lloyd J
49220-Nov-2023Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adults.Slee, Michael G; Rainey-Smith, Stephanie R; Villemagne, Victor L ; Doecke, James D; Sohrabi, Hamid R; Taddei, Kevin; Ames, David; Doré, Vincent ; Maruff, Paul; Laws, Simon M; Masters, Colin L ; Rowe, Christopher C ; Martins, Ralph N; Erickson, Kirk I; Brown, Belinda M
4932020Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's Disease.Lim, Yen Ying; Maruff, Paul; Kaneko, Naoki; Doecke, James; Fowler, Christopher; Villemagne, Victor L ; Kato, Takashi; Rowe, Christopher C ; Arahata, Yutaka; Iwamoto, Shinichi; Ito, Kengo; Tanaka, Koichi; Yanagisawa, Katsuhiko; Masters, Colin L ; Nakamura, Akinori
4942014Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden.Rembach, Alan; Watt, Andrew D; Wilson, William J; Villemagne, Victor L ; Burnham, Samantha C; Ellis, Kathryn A; Maruff, Paul; Ames, David; Rowe, Christopher C ; Macaulay, S Lance; Bush, Ashley I; Martins, Ralph N; Masters, Colin L ; Doecke, James D
49522-Dec-2015Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of agingGupta, VB; Doecke, JD; Hone, E; Pedrini, S; Laws, Simon M; Thambisetty, M; Bush, AI; Rowe, Christopher C ; Villemagne, Victor L ; Ames, David; Masters, Colin L ; Macaulay, S Lance; Rembach, A; Rainey-Smith, Stephanie R; Martins, Ralph N; AIBL Research Group
496Apr-2023Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.Chatterjee, Pratishtha; Pedrini, Steve; Doecke, James D; Thota, Rohith; Villemagne, Victor L ; Doré, Vincent ; Singh, Abhay K; Wang, Penghao; Rainey-Smith, Stephanie; Fowler, Christopher; Taddei, Kevin; Sohrabi, Hamid R; Molloy, Mark P; Ames, David; Maruff, Paul; Rowe, Christopher C ; Masters, Colin L ; Martins, Ralph N
497Jan-2017Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer's Disease: A 6-Year Prospective Cohort Study.Pietrzak, Robert H; Laws, Simon M; Lim, Yen Ying; Bender, Sophie J; Porter, Tenielle; Doecke, James; Ames, David; Fowler, Christopher; Masters, Colin L ; Milicic, Lidija; Rainey-Smith, Stephanie R; Villemagne, Victor L ; Rowe, Christopher C ; Martins, Ralph N; Maruff, Paul
4989-Feb-2023Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.Chatterjee, Pratishtha; Doré, Vincent ; Pedrini, Steve; Krishnadas, Natasha ; Thota, Rohith; Bourgeat, Pierrick; Ikonomovic, Milos D; Rainey-Smith, Stephanie R; Burnham, Samantha C; Fowler, Christopher; Taddei, Kevin; Mulligan, Rachel S ; Ames, David; Masters, Colin L ; Fripp, Jürgen; Rowe, Christopher C ; Martins, Ralph N; Villemagne, Victor L 
49911-Jan-2021Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease.Chatterjee, Pratishtha; Pedrini, Steve; Stoops, Erik; Goozee, Kathryn; Villemagne, Victor L ; Asih, Prita R; Verberk, Inge M W; Dave, Preeti; Taddei, Kevin; Sohrabi, Hamid R; Zetterberg, Henrik; Blennow, Kaj; Teunissen, Charlotte E; Vanderstichele, Hugo M; Martins, Ralph N
5002020Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.Pedrini, Steve; Hone, Eugene; Gupta, Veer B; James, Ian; Teimouri, Elham; Bush, Ashley I; Rowe, Christopher C ; Villemagne, Victor L ; Ames, David; Masters, Colin L ; Rainey-Smith, Stephanie; Verdile, Giuseppe; Sohrabi, Hamid R; Raida, Manfred R; Wenk, Markus R; Taddei, Kevin; Chatterjee, Pratishtha; Martins, Ian; Laws, Simon M; Martins, Ralph N